![Bill Lundberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bill Lundberg
Direttore/Membro del Consiglio presso
Q32 Bio, Inc.
Patrimonio netto: 15 288 $ in data 30/06/2026
Profilo
Sven Ante Lundberg is currently Director at Q32 Bio Operations, Inc. and Independent Director at Q32 Bio, Inc. since 2024.
Former positions include President, CEO & Executive Director at Merus NV from 2023 to 2025; Independent Director at Vor Biopharma, Inc. from 2019 to 2025; Chief Scientific Officer at CRISPR Therapeutics AG from 2015 to 2018; Vice President & Head-Translational Medicine at Alexion Pharmaceuticals, Inc. from 2011 to 2015; Director & Chief Medical Officer at Taligen Therapeutics, Inc. from 2010 to 2012; Medical Director at Wyeth LLC and Genzyme Corp.; Director at Alliance for Regenerative Medicine; Principal at Antisoma Research Ltd. and Antisoma, Inc.; Vice President-Clinical Development at Sarossa Capital Ltd. Education includes undergraduate studies at Massachusetts Institute of Technology, MBA degrees from the University of Massachusetts and The Isenberg School of Management, and a doctorate from Stanford University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0,01% | 12/06/2026 | 1.200 ( 0,01% ) | 15 288 $ | 30/06/2026 |
Posizioni attive di Bill Lundberg
| Società | Posizione | Inizio |
|---|---|---|
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Bill Lundberg
| Società | Posizione | Fine |
|---|---|---|
| MERUS N.V. | Amministratore Delegato | 12/12/2025 |
| VOR BIOPHARMA INC. | Direttore/Membro del Consiglio | 17/07/2025 |
| CRISPR THERAPEUTICS AG | Direttore Tecnico/Scientifico/R&S | 08/02/2018 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2015 |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops inflammatory disease pharamaceutical products | Direttore Tecnico/Scientifico/R&S | 24/02/2012 |
Formazione di Bill Lundberg
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
53
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Antisoma Research Ltd. | |
Taligen Therapeutics, Inc.
Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops inflammatory disease pharamaceutical products | Health Technology |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Antisoma, Inc.
 Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceuticals | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Isenberg School of Management
 The Isenberg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
